4.8 Article

The IUPHAR/BPS Guide to PHARMACOLOGY in 2020: extending immunopharmacology content and introducing the IUPHAR/MMV Guide to MALARIA PHARMACOLOGY

期刊

NUCLEIC ACIDS RESEARCH
卷 48, 期 D1, 页码 D1006-D1021

出版社

OXFORD UNIV PRESS
DOI: 10.1093/nar/gkz951

关键词

-

资金

  1. International Union of Basic and Clinical Pharmacology
  2. British Pharmacological Society [MED791]
  3. Wellcome Trust [108420/Z/15/Z]
  4. Medicines for Malaria Venture [CT-5535]
  5. American Society for Pharmacology and Experimental Therapeutics
  6. Laboratoires Servier
  7. University of Edinburgh
  8. Wellcome Trust [108420/Z/15/Z] Funding Source: Wellcome Trust

向作者/读者索取更多资源

The IUPHAR/BPS Guide to PHARMACOLOGY (www.guidetopharmacology.org ) is an open-access, expert-curated database of molecular interactions between ligands and their targets. We describe significant updates made over the seven releases during the last two years. The database is notably enhanced through the continued linking of relevant pharmacology with key immunological data types as part of the IUPHAR Guide to IMMUNOPHARMACOLOGY (www.guidetoimmunopharmacology.org ) and by a major new extension, the IUPHAR/MMV Guide to Malaria PHARMACOLOGY (www. guidetomalariapharmacology.org ). The latter has been constructed in partnership with the Medicines for Malaria Venture, an organization dedicated to identifying, developing and delivering new antimalarial therapies that are both effective and affordable. This is in response to the global challenge of over 200 million cases of malaria and 400 000 deaths worldwide, with the majority in the WHO Africa Region. It provides new pharmacological content, including molecular targets in the malaria parasite, interaction data for ligands with antimalarial activity, and establishes curation of data from screening assays, used routinely in antimalarial drug discovery, against the whole organism. A dedicated portal has been developed to provide quick and focused access to these new data.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据